Aguiar Cassyanne L, Soybilgic Arzu, Avcin Tadej, Myones Barry L
Pediatric Rheumatology, Cohen Children's Medical Center-North Shore Long Island Jewish Medical Center, The Hofstra North Shore-LIJ School of Medicine, 1991 Marcus Avenue, Suite M100, Lake Success, NY, 11040, USA,
Curr Rheumatol Rep. 2015 Apr;17(4):27. doi: 10.1007/s11926-015-0504-5.
Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk, and effective treatment) in pediatric APS. The purpose of this report is to review the current literature on APS in children and neonates, identify the gaps in current knowledge, and suggest avenues for studies to fill those gaps.
抗磷脂综合征(APS)是一种多系统自身免疫性疾病,其特征为与抗磷脂抗体持续阳性相关的血管血栓形成。目前关于儿童抗磷脂综合征的数据(发病率、患病率、血栓形成风险及有效治疗方法)较为匮乏。本报告的目的是回顾当前有关儿童及新生儿抗磷脂综合征的文献,找出当前知识中的空白,并提出填补这些空白的研究途径。